Polaris Quantum Biotech (POLARISqb), is developing QuADD (Quantum Aided Drug Design), a subscription-based SaaS product that finds your Lead-like Hits from a library of 10^30 molecules (and growing) in 1-2 days and answers the question of “When looking for new drugs, where do you start?”. The output of QuADD is an enriched, diverse and superior molecular library for a specific protein target. In this presentation, we will discuss the requirements and quantum technology behind QuADD, as well as several case studies.

Bill Shipman, CTO, Polaris Quantum Biotech